Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report

T-cell prolymphocytic leukemia (T-PLL) is a rare aggressive disease with a poor prognosis. Allogeneic stem cell transplantation (allo-SCT) followed by alemtuzumab administration is the most promising treatment for T-PLL but is associated with a high risk of infections as alemtuzumab strongly suppres...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Naoki, Yamamoto, Ryusuke, Maruoka, Hayato, Himeno, Mayuko, Hiramoto, Nobuhiro, Ishikawa, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601731/
https://www.ncbi.nlm.nih.gov/pubmed/37900793
http://dx.doi.org/10.1159/000531471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601731/
https://www.ncbi.nlm.nih.gov/pubmed/37900793
http://dx.doi.org/10.1159/000531471

Ejemplares similares